95 related articles for article (PubMed ID: 2156061)
21. Glycine-evoked neurotransmitter release from rat hippocampal brain slices: evidence for the involvement of glutaminergic transmission.
Mangano TJ; Patel J; Salama AI; Keith RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):574-80. PubMed ID: 2156052
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the effects of omega-conotoxin GVIA on the responses of voltage-sensitive calcium channels.
Keith RA; Mangano TJ; Pacheco MA; Salama AI
J Auton Pharmacol; 1989 Aug; 9(4):243-52. PubMed ID: 2570074
[TBL] [Abstract][Full Text] [Related]
23. Social isolation increases the density of [125I]omega-conotoxin GVIA binding sites in the rat frontal cortex and caudate nucleus.
Czyrak A; Dooley DJ; Jones GH; Robbins TW
Brain Res; 1992 Jun; 583(1-2):189-93. PubMed ID: 1324093
[TBL] [Abstract][Full Text] [Related]
24. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes.
Knaus HG; Striessnig J; Koza A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):583-6. PubMed ID: 2830547
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel.
Dooley DJ; Lupp A; Hertting G
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):467-70. PubMed ID: 2448660
[TBL] [Abstract][Full Text] [Related]
26. Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.
Dooley DJ; Lupp A; Hertting G; Osswald H
Eur J Pharmacol; 1988 Mar; 148(2):261-7. PubMed ID: 3378575
[TBL] [Abstract][Full Text] [Related]
27. Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine.
Kimura T; Takeuchi A; Satoh S
Eur J Pharmacol; 1994 Oct; 264(2):169-75. PubMed ID: 7851479
[TBL] [Abstract][Full Text] [Related]
28. Distribution of N-type Ca2+ channel binding sites in rabbit brain following central administration of omega-conotoxin GVIA.
Whorlow SL; Loiacono RE; Angus JA; Wright CE
Eur J Pharmacol; 1996 Nov; 315(1):11-8. PubMed ID: 8960859
[TBL] [Abstract][Full Text] [Related]
29. Evidence of omega-conotoxin GV1A-sensitive Ca2+ channels in mammalian peripheral nerve terminals.
Lundy PM; Frew R
Eur J Pharmacol; 1988 Nov; 156(3):325-30. PubMed ID: 2850931
[TBL] [Abstract][Full Text] [Related]
30. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices.
Dooley DJ; Donovan CM; Meder WP; Whetzel SZ
Synapse; 2002 Sep; 45(3):171-90. PubMed ID: 12112396
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex.
Jackisch R; Förster S; Kammerer M; Rothmaier AK; Ehret A; Zentner J; Feuerstein TJ
J Alzheimers Dis; 2009; 16(3):635-47. PubMed ID: 19276558
[TBL] [Abstract][Full Text] [Related]
32. Identification of omega-conotoxin binding sites on adrenal medullary membranes: possibility of multiple calcium channels in chromaffin cells.
Jan CR; Titeler M; Schneider AS
J Neurochem; 1990 Jan; 54(1):355-8. PubMed ID: 2152797
[TBL] [Abstract][Full Text] [Related]
33. K(+)-evoked [(3)H]-norepinephrine release in human brain slices from epileptic and non-epileptic patients is differentially modulated by gabapentin and pinacidil.
Freiman TM; Surges R; Kukolja J; Heinemeyer J; Klar M; van Velthoven V; Zentner J
Neurosci Res; 2006 Jun; 55(2):204-10. PubMed ID: 16650496
[TBL] [Abstract][Full Text] [Related]
34. Effects of omega-conotoxin GVIA on cardiac sympathetic nerve function.
Yahagi N; Akiyama T; Yamazaki T
J Auton Nerv Syst; 1998 Jan; 68(1-2):43-8. PubMed ID: 9531444
[TBL] [Abstract][Full Text] [Related]
35. Adrenergic inhibition of endogenous acetylcholine release on postganglionic cardiac vagal nerve terminals.
Akiyama T; Yamazaki T
Cardiovasc Res; 2000 Jun; 46(3):531-8. PubMed ID: 10912463
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery.
Clasbrummel B; Osswald H; Illes P
Br J Pharmacol; 1989 Jan; 96(1):101-10. PubMed ID: 2924067
[TBL] [Abstract][Full Text] [Related]
37. Binding of omega-conotoxin to receptor sites associated with the voltage-sensitive calcium channel.
Abe T; Koyano K; Saisu H; Nishiuchi Y; Sakakibara S
Neurosci Lett; 1986 Nov; 71(2):203-8. PubMed ID: 2431360
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of acetylcholine release by homoanatoxin-a from Oscillatoria formosa.
Aas P; Eriksen S; Kolderup J; Lundy P; Haugen JE; Skulberg OM; Fonnum F
Environ Toxicol Pharmacol; 1996 Oct; 2(2-3):223-32. PubMed ID: 21781731
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the omega-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types.
Cruz LJ; Johnson DS; Olivera BM
Biochemistry; 1987 Feb; 26(3):820-4. PubMed ID: 2436655
[TBL] [Abstract][Full Text] [Related]
40. Modulation of acetylcholine release in human cortical slices: possible implications for Alzheimer's disease.
Feuerstein TJ; Seeger W
Pharmacol Ther; 1997; 74(3):333-47. PubMed ID: 9352588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
